Fyn Mediates High Glucose-Induced Actin Cytoskeleton Reorganization of Podocytes via Promoting ROCK Activation in Vitro

Journal of Diabetes Research

Volumn 2016, Issue , 2016, Pages

  Lv, Zhimei ^a   Hu, Mengsi ^a   Ren, Xiaoxu ^a   Fan, Minghua ^b   Zhen, Junhui ^c   Chen, Liqun ^d   Lin, Jiangong ^a   Ding, Nannan ^a   Wang, Qun ^a   Wang, Rong ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^c SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; DESMIN; F ACTIN; GLUCOSE; PAXILLIN; PROTEIN KINASE FYN; SMALL INTERFERING RNA; SYNAPTOPODIN; VIMENTIN; ACTIN; FYN PROTEIN, MOUSE; GLUCOSE BLOOD LEVEL; MEMBRANE PROTEIN; NEPHRIN; RHO KINASE;

ACTIN FILAMENT; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; ENZYME ACTIVATION; GENE SILENCING; GENETIC TRANSFECTION; GLOMERULUS FILTRATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; MOUSE; NONHUMAN; OSMOTIC PRESSURE; PODOCYTE; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WOUND HEALING; ANIMAL; CELL MOTION; CHEMISTRY; CYTOLOGY; GLUCOSE BLOOD LEVEL; METABOLISM; PHOSPHORYLATION; RNA INTERFERENCE;

ACTIN CYTOSKELETON; ACTINS; ANIMALS; BLOOD GLUCOSE; CELL MOVEMENT; GLUCOSE; MEMBRANE PROTEINS; MICE; PAXILLIN; PHOSPHORYLATION; PODOCYTES; PROTO-ONCOGENE PROTEINS C-FYN; RHO-ASSOCIATED KINASES; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 84956539583     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2016/5671803     Document Type: Article

References (43)

1. K. Susztak, A. C. Raff, M. Schiffer, and E. P. Böttinger, "Glucoseinduced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy, " Diabetes, vol. 55, no. 1, pp. 225-233, 2006.
2. G. Wolf, S. Chen, and F. N. Ziyadeh, "Fromthe periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy, " Diabetes, vol. 54, no. 6, pp. 1626-1634, 2005.
3. E. J. Weil, K. V. Lemley, C. C. Mason et al., "Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy, " Kidney International, vol. 82, no. 9, pp. 1010-1017, 2012.
4. C. Faul, K. Asanuma, E. Yanagida-Asanuma, K. Kim, and P. Mundel, "Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton, " Trends in Cell Biology, vol. 17, no. 9, pp. 428-437, 2007.
5. S. J. Shankland, "The podocyte's response to injury: role in proteinuria and glomerulosclerosis, " Kidney International, vol. 69, no. 12, pp. 2131-2147, 2006.
6. D. Smyth, V. Phan, A. Wang, and D.M. McKay, "Interferon-induced increases in intestinal epithelial macromolecular permeability requires the Src kinase Fyn, " Laboratory Investigation, vol. 91, no. 5, pp. 764-777, 2011.
7. J.W. Um, H.B. Nygaard, J.K. Heiss et al., "Alzheimer amyloid-oligomer bound to postsynaptic prion protein activates Fyn to impair neurons, " Nature Neuroscience, vol. 15, no. 9, pp. 1227-1235, 2012.
8. E. M. Posadas, H. Al-Ahmadie, V. L. Robinson et al., "FYN is overexpressed in human prostate cancer, " BJU International, vol. 103, no. 2, pp. 171-177, 2009.
9. Y. D. Saito, A. R. Jensen, R. Salgia, and E. M. Posadas, "Fyn: A novel molecular target in cancer, " Cancer, vol. 116, no. 7, pp. 1629-1637, 2010.
10. H. Li, S. Lemay, L. Aoudjit, H. Kawachi, and T. Takano, "Srcfamily kinase Fyn phosphorylates the cytoplasmic domain of nephrin and modulates its interaction with podocin, " Journal of the American Society of Nephrology, vol. 15, no. 12, pp. 3006-3015, 2004.
11. M. Maekawa, T. Ishizaki, S. Boku et al., "Signaling from Rho to the actin cytoskeleton through protein kinases ROCKand LIMkinase, " Science, vol. 285, no. 5429, pp. 895-898, 1999.
12. R. Verma, B. Wharram, I. Kovari et al., "Fyn binds to and phosphorylates the kidney slit diaphragmcomponentNephrin, " The Journal of Biological Chemistry, vol. 278, no. 23, pp. 20716-20723, 2003.
13. S. Narumiya, M. Tanji, and T. Ishizaki, "Rho signaling, ROCK andmDia1, in transformation, metastasis and invasion, " Cancer and Metastasis Reviews, vol. 28, no. 1-2, pp. 65-76, 2009.
14. D. Xu, H. Kishi, H. Kawamichi, K. Kajiya, Y. Takada, and S. Kobayashi, "Involvement of Fyn tyrosine kinase in actin stress fiber formation in fibroblasts, " FEBS Letters, vol. 581, no. 27, pp. 5227-5233, 2007.
15. A. Gojo, K. Utsunomiya, K. Taniguchi et al., "The Rhokinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats, " European Journal of Pharmacology, vol. 568, no. 1-3, pp. 242-247, 2007.
16. Y. Kikuchi, M. Yamada, T. Imakiire et al., "A Rho-kinase inhibitor, fasudil, prevents development of diabetes and nephropathy in insulin-resistant diabetic rats, " Journal of Endocrinology, vol. 192, no. 3, pp. 595-603, 2007.
17. F. Peng, D. Wu, B. Gao et al., "RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease, " Diabetes, vol. 57, no. 6, pp. 1683-1692, 2008.
18. R. Komers, T. T. Oyama, D. R. Beard et al., "Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure, " Kidney International, vol. 79, no. 4, pp. 432-442, 2011.
19. P. Mundel, J. Reiser, A. Z. M. Borja et al., "Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines, " Experimental Cell Research, vol. 236, no. 1, pp. 248-258, 1997.
20. H. Pavenstädt, W. Kriz, and M. Kretzler, "Cell biology of the glomerular podocyte, " Physiological Reviews, vol. 83, no. 1, pp. 253-307, 2003.
21. S. Doublier, G. Salvidio, E. Lupia et al., "Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II, " Diabetes, vol. 52, no. 4, pp. 1023-1030, 2003.
22. P. Mundel and S. J. Shankland, "Podocyte biology and response to injury, " Journal of the American Society of Nephrology, vol. 13, no. 12, pp. 3005-3015, 2002.
23. Z. Lv, M. Hu, J. Zhen, J. Lin, Q. Wang, and R. Wang, "Rac1/PAK1 signaling promotes epithelial-mesenchymal transition of podocytes in vitro via triggering -catenin transcriptional activity under high glucose conditions, "The International Journal of Biochemistry & Cell Biology, vol. 45, no. 2, pp. 255-264, 2013.
24. M. Herman-Edelstein, M. C. Thomas, V. Thallas-Bonke, M. Saleem, M. E. Cooper, and P. Kantharidis, "Dedifferentiation of immortalized human podocytes in response to transforming growth factor-: A model for diabetic podocytopathy, " Diabetes, vol. 60, no. 6, pp. 1779-1788, 2011.
25. J. Zou, E. Yaoita, Y. Watanabe et al., "Upregulation of nestin, vimentin, and desmin in rat podocytes in response to injury, " Virchows Archiv, vol. 448, no. 4, pp. 485-492, 2006.
26. L. S. Laursen, C. W. Chan, and C. Ffrench-Constant, "An integrin-contactin complex regulates CNS myelination by differential Fyn phosphorylation, "TheJournal of Neuroscience, vol. 29, no. 29, pp. 9174-9185, 2009.
27. V. Kolavennu, L. Zeng, H. Peng, Y. Wang, and F. R. Danesh, "Targeting of RhoA/ROCKsignalingameliorates progression of diabetic nephropathy independent of glucose control, " Diabetes, vol. 57, no. 3, pp. 714-723, 2008.
28. M. D. Schaller, "Paxillin: A focal adhesion-Associated adaptor protein, " Oncogene, vol. 20, no. 44, pp. 6459-6472, 2001.
29. D. J. Webb, K. Donais, L. A. Whitmore et al., "FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly, " Nature Cell Biology, vol. 6, no. 2, pp. 154-161, 2004.
30. Z.-M. Lv, Q. Wang, Q. Wan et al., "The role of the p38 MAPK signaling pathway in high glucose-induced epithelialmesenchymal transition of cultured human renal tubular epithelial cells, " PLoS ONE, vol. 6, no. 7, Article ID e22806, 2011.
31. M. Lin, W. H. Yiu, H. J. Wu et al., "Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy, " Journal of the American Society of Nephrology, vol. 23, no. 1, pp. 86-102, 2012.
32. J. J. Li, S. J. Kwak, D. S. Jung et al., "Podocyte biology in diabetic nephropathy, " Kidney International, vol. 72, no. 106, pp. S36-S42, 2007.
33. K. Asanuma, E. Yanagida-Asanuma, C. Faul, Y. Tomino, K. Kim, and P. Mundel, "Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling, " Nature Cell Biology, vol. 8, no. 5, pp. 485-491, 2006.
34. C. Wei, C. C. Möller, M. M. Altintas et al., "Modification of kidney barrier function by the urokinase receptor, " Nature Medicine, vol. 14, no. 1, pp. 55-63, 2008.
35. A. Kuhlmann, C. S. Haas, M.-L. Gross et al., "1, 25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat, " American Journal of Physiology-Renal Physiology, vol. 286, no. 3, pp. F526-F533, 2004.
36. J. Chin, J. J. Palop, G.-Q. Yu, N. Kojima, E. Masliah, and L. Mucke, "Fyn kinasemodulates synaptotoxicity, but not aberrant sprouting, in human amyloid precursor protein transgenic mice, " Journal of Neuroscience, vol. 24, no. 19, pp. 4692-4697, 2004.
37. N. Kobayashi, "Mechanismof the process formation; podocytes vs. neurons, " Microscopy Research and Technique, vol. 57, no. 4, pp. 217-223, 2002.
38. A. S. Baer, Y. A. Syed, S. U. Kang et al., "Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling, " Brain, vol. 132, no. 2, pp. 465-481, 2009.
39. H. Ma, A. Togawa, K. Soda et al., "Inhibition of podocyte FAK protects against proteinuria and foot process effacement, " Journal of the American Society of Nephrology, vol. 21, no. 7, pp. 1145-1156, 2010.
40. K. Azuma, M. Tanaka, T. Uekita et al., "Tyrosine phosphorylation of paxillin affects the metastatic potential of human osteosarcoma, " Oncogene, vol. 24, no. 30, pp. 4754-4764, 2005.
41. X. Li, Y. Yang, Y. Hu et al., "v6-Fyn signaling promotes oral cancer progression, " Journal of Biological Chemistry, vol. 278, no. 43, pp. 41646-41653, 2003.
42. M. Hirakawa, M. Oike, Y. Karashima, and Y. Ito, "Sequential activation of RhoA and FAK/paxillin leads to ATP release and actin reorganization in human endothelium, " The Journal of Physiology, vol. 558, no. 2, pp. 479-488, 2004.
43. J. Sinnett-Smith, J. A. Lunn, D. Leopoldt, and E. Rozengurt, "Y-27632, an inhibitor of Rho-Associated kinases, prevents tyrosine phosphorylation of focal adhesion kinase and paxillin induced by bombesin: dissociation from tyrosine phosphorylation of p130cas, " Experimental Cell Research, vol. 266, no. 2, pp. 292-302, 2001.